These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

227 related items for PubMed ID: 6306497

  • 1. [Anti-tumor activity of ACNU against malignant glioma--a clinical application of in vitro sensitivity test of chemotherapeutic agent].
    Shibuya N, Yoshida J, Kobayashi T, Kageyama N.
    No Shinkei Geka; 1983 Apr; 11(4):361-7. PubMed ID: 6306497
    [Abstract] [Full Text] [Related]

  • 2. [Evaluation of ACNU alone and combined with tegafur as additions to radiotherapy of the treatment of malignant gliomas--a cooperative clinical trial].
    Ushio Y, Abe H, Suzuki J, Tanaka R, Kitamura K, Miwa T, Matsutani M, Takeuchi K, Takakura K, Nomura K.
    No To Shinkei; 1985 Oct; 37(10):999-1006. PubMed ID: 3000412
    [Abstract] [Full Text] [Related]

  • 3. [ACNU delivery to malignant tumor tissue and serum--route of administration and combined use of phenobarbital].
    Muraoka K.
    No To Shinkei; 1983 Dec; 35(12):1199-206. PubMed ID: 6584117
    [Abstract] [Full Text] [Related]

  • 4. In vitro sensitivity of nitrosourea-induced neurogenic tumors to ACNU.
    Kida Y, Cravioto H, Hochwald G, Ransohoff J.
    Anticancer Res; 1982 Dec; 2(1-2):79-87. PubMed ID: 6956245
    [Abstract] [Full Text] [Related]

  • 5. [Chemotherapeutic strategy in rat brain tumor cells resistant to ACNU using an in vitro colony formation assay].
    Mineura K, Sasaki J, Fushimi S, Sasajima H, Ishino Y, Kowada M.
    No To Shinkei; 1989 Sep; 41(9):927-32. PubMed ID: 2590562
    [Abstract] [Full Text] [Related]

  • 6. Down-regulation of O6-methylguanine-DNA methyltransferase gene expression in gliomas by platinum compounds.
    Tanaka S, Kobayashi I, Utsuki S, Oka H, Yasui Y, Fujii K.
    Oncol Rep; 2005 Nov; 14(5):1275-80. PubMed ID: 16211296
    [Abstract] [Full Text] [Related]

  • 7. [Synchronization chemoradiotherapy for malignant gliomas].
    Yamamoto H, Sato F, Nakamura O, Kohno T, Shitara N, Takakura K, Sano K, Maehara T, Akanuma A.
    No Shinkei Geka; 1984 Jun; 12(7):795-805. PubMed ID: 6592471
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Studies on the mechanism of ACNU resistance in sublines of rat C6 glioma and 9L gliosarcoma in vitro].
    Yoshida T, Shimizu K, Ushio Y, Hayakawa T, Kato A, Mogami H, Sakamoto Y.
    No Shinkei Geka; 1986 Oct; 14(11):1299-304. PubMed ID: 3468375
    [Abstract] [Full Text] [Related]

  • 10. Differential sensitivity of malignant glioma cells to methylating and chloroethylating anticancer drugs: p53 determines the switch by regulating xpc, ddb2, and DNA double-strand breaks.
    Batista LF, Roos WP, Christmann M, Menck CF, Kaina B.
    Cancer Res; 2007 Dec 15; 67(24):11886-95. PubMed ID: 18089819
    [Abstract] [Full Text] [Related]

  • 11. [Development of ACNU-resistant meningeal gliomatosis models: establishment of resistant rat glioma subline against ACNU].
    Yoshida T, Ushio Y, Hayakawa T, Yamada K, Kato A, Mogami H, Nakata Y.
    No Shinkei Geka; 1984 Aug 15; 12(9):1029-36. PubMed ID: 6594599
    [Abstract] [Full Text] [Related]

  • 12. [Therapeutic effects of 1-(4-amino-2-methyl-5-pyrimidinyl) methyl-3-(2-chloroethyl)-3-nitrosourea hydrochloride (ACNU) and radiation on the rat glioma (author's transl)].
    Mineura K, Mori T, Katakura R, Sasaki T.
    No Shinkei Geka; 1981 Aug 15; 9(3):257-65. PubMed ID: 6941099
    [No Abstract] [Full Text] [Related]

  • 13. Neuro-Oncology Working Group 01 trial of nimustine plus teniposide versus nimustine plus cytarabine chemotherapy in addition to involved-field radiotherapy in the first-line treatment of malignant glioma.
    Weller M, Müller B, Koch R, Bamberg M, Krauseneck P, Neuro-Oncology Working Group of the German Cancer Society.
    J Clin Oncol; 2003 Sep 01; 21(17):3276-84. PubMed ID: 12947063
    [Abstract] [Full Text] [Related]

  • 14. [Intra-arterial ACNU chemotherapy of malignant glioma].
    Murayama S, Kawai R, Hirabuki N, Miura T, Mitomo M, Kozuka T, Usio Y.
    Nihon Igaku Hoshasen Gakkai Zasshi; 1988 Feb 25; 48(2):144-53. PubMed ID: 3164472
    [No Abstract] [Full Text] [Related]

  • 15. [Experimental studies on the treatment of recurrent gliomas].
    Yamada M, Shimizu K, Okamoto Y, Miyao Y, Matsui Y, Tsuda N, Mogami H.
    Gan To Kagaku Ryoho; 1987 Jun 25; 14(6 Pt 1):1890-5. PubMed ID: 3496051
    [Abstract] [Full Text] [Related]

  • 16. [Effect of ACNU, a water-soluble nitrosourea, on cell cycle of cultured glioma cells--flow cytometric analysis].
    Fujiwara T, Nakasone S, Matsumoto K, Ohnishi R, Tabuchi K, Nishimoto A.
    Gan To Kagaku Ryoho; 1983 Sep 25; 10(9):2055-61. PubMed ID: 6577816
    [Abstract] [Full Text] [Related]

  • 17. [Anticancer drug induced sister chromatid exchange and correlation to cell survival in human brain tumor cells].
    Aida T, Bodell WJ.
    No To Shinkei; 1987 Mar 25; 39(3):235-41. PubMed ID: 3472531
    [Abstract] [Full Text] [Related]

  • 18. [ACNU delivery to malignant glioma tissue by osmotic blood brain barrier modification with intracarotid infusion of hyperosmoral mannitol].
    Miyagami M, Kagawa Y, Tsubokawa T.
    No Shinkei Geka; 1985 Sep 25; 13(9):955-63. PubMed ID: 2999632
    [Abstract] [Full Text] [Related]

  • 19. Modulation in vitro and in vivo of ACNU resistance in a subline of C6 glioma with reserpine.
    Yoshida T, Shimizu K, Ushio Y, Mogami H, Sakamoto Y.
    J Neurosurg; 1987 Feb 25; 66(2):251-5. PubMed ID: 3468207
    [Abstract] [Full Text] [Related]

  • 20. [Possibility of overcoming of ACNU resistance in an ACNU-resistant subline of C6 rat glioma].
    Yoshida T, Shimizu K, Ushio Y, Mogami H, Sakamoto Y.
    No To Shinkei; 1986 Nov 25; 38(11):1065-70. PubMed ID: 3468959
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.